SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform

MitoCareX Bio has met its second milestone as part of its joint venture agreement with the Company TEL AVIV, Israel, Nov. 27, 2023 -- SciSparc Ltd. , a specialty clinical-stage...

Related Keywords

Israel ,Mitocarex Bio ,Mitocarex Bio Ltd ,Company Or Scisparc ,Scisparc Ltd ,Exchange Commission ,Nasdaq ,Alon Silberman ,Investment Agreement ,Carex Bio ,Solute Carrier Family ,Tourette Syndrome ,Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,Markets ,